Key result
Drug-eluting stents showed poorer endothelialization and greater delayed healing compared with bare-metal stents of similar implant duration.
Why the study?
Data suggested the window of thrombotic risk for DES extends far beyond that for BMS, prompting evaluation of long-term arterial healing and mechanisms underlying late stent thrombosis.
Observational (n=48)
Answers are grounded in this paper and cite their sources.
OBJECTIVES: This study examined human drug-eluting stents (DES) to determine the long-term effects of these stents on coronary arterial healing and identified mechanisms underlying late stent thrombosis (LST). BACKGROUND: Although DES reduce the need for repeat revascularization compared with bare-metal stents (BMS), data suggest the window of thrombotic risk for Cypher (Cordis Corp., Miami Lakes, Florida) and Taxus (Boston Scientific Corp., Natick, Massachusetts) DES extends far beyond that for BMS. METHODS: From a registry of 40 autopsies of DES (68 stents), 23 DES cases of >30 days duration were compared with 25 matched autopsies of BMS implantation. Late stent thrombosis was defined as an acute thrombus within a stent >30 days old. RESULTS: Of 23 patients with DES >30 days old, 14 had evidence of LST. Cypher and Taxus DES showed greater delayed healing characterized by persistent fibrin deposition (fibrin score 2.3 +/- 1.1 vs. 0.9 +/- 0.8, p = 0.0001) and poorer endothelialization (55.8 +/- 26.5%) compared with BMS (89.8 +/- 20.9, p = 0.0001). Moreover, DES with LST showed more delayed healing compared with patent DES. In 5 of 14 patients suffering LST, antiplatelet therapy had been withdrawn. Additional procedural and pathologic risk factors for LST were: 1) local hypersensitivity reaction; 2) ostial and/or bifurcation stenting; 3) malapposition/incomplete apposition; 4) restenosis; and 5) strut penetration into a necrotic core. CONCLUSIONS: The Cypher and Taxus DES result in delayed arterial healing when compared with BMS of similar implant duration. The cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role.
No takes yet. Share an insight, caveat, or question.
Joner et al. (2006) conducted an observational in Coronary artery disease with stent implantation (n=48). Drug-eluting stents (Cypher and Taxus) vs. Bare-metal stents was evaluated on Endothelialization (p=0.0001). Drug-eluting stents showed poorer endothelialization and greater delayed healing compared with bare-metal stents of similar implant duration.
Synapse has enriched 10 related papers. Consider them for comparative context: